Page 6 - Patrick Mcnutt News Today

StockNews.com downgraded shares of Darling Ingredients (NYSE:DAR – Get Rating) from a hold rating to a sell rating in a report published on Tuesday morning. DAR has been the topic of a number of other research reports. Raymond James reduced their price target on Darling Ingredients from $100.00 to $95.00 and set a strong-buy rating […]

Redwood Investments LLC purchased a new stake in shares of Darling Ingredients Inc. (NYSE:DAR – Get Rating) in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor purchased 32,685 shares of the company’s stock, valued at approximately $2,046,000. Other large investors have also added […]

Seelaus Asset Management LLC decreased its holdings in Darling Ingredients Inc. (NYSE:DAR – Get Rating) by 3.8% during the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 7,659 shares of the company’s stock after selling 301 shares during the period. Seelaus Asset Management LLC’s holdings in Darling Ingredients were […]

Beacon Financial Group trimmed its position in shares of Darling Ingredients Inc. (NYSE:DAR – Get Rating) by 15.4% during the fourth quarter, Holdings Channel reports. The firm owned 40,509 shares of the company’s stock after selling 7,390 shares during the quarter. Beacon Financial Group’s holdings in Darling Ingredients were worth $2,535,000 at the end of […]

AE Wealth Management LLC reduced its holdings in shares of Darling Ingredients Inc. (NYSE:DAR – Get Rating) by 6.3% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 3,860 shares of the company’s stock after selling 261 shares during the quarter. AE Wealth […]

Botulism is a rare but deadly disease, and researchers at the Wake Forest Institute for Regenerative Medicine (WFIRM) are looking into a drug that is used to treat neuromuscular weakness as a potential treatment.

Wake Forest Institute for Regenerative Medicine (WFIRM) researchers are investigating a drug used to treat neuromuscular weakness as a potential treatment for botulism, a rare but serious disease.

The Wake Forest Institute for Regenerative Medicine has received a $36 million federal award to establish a research and development program to study the ways in which a virus will

Members of the Chippewa school board heard updates from the superintendent on a school bus program and a natural gas leak at the Intermediate School.

NIH-KI Program Student Profiles